Are payors clobbering clinical laboratories and pathology groups? It sure has seemed that way this past year and it doesn’t look like this will ease up in 2018. Powerful commercial payors will continue to exert pressure on all players in the healthcare arena through plan design. This includes narrow networks as well as the use of co-pays and deductibles to encourage use of lower-cost providers and services. Now more than ever, laboratories need to effectively innovate. COMPLETE POST COMING SOON.